The Abdominal Aortic Aneurysm (AAA) Repair Devices Market is expanding as healthcare systems increasingly adopt minimally invasive approaches for the treatment of abdominal aortic aneurysms. One market estimate places the global market at US$ 3.2 billion in 2025 and projects it to reach US$ 5.8 billion by 2033, registering a CAGR of 7.3% during 2026–2033. Growth is supported by the increasing prevalence of AAA, an aging population, improvements in vascular imaging, and wider adoption of endovascular aneurysm repair (EVAR).

What is driving the market?

The increasing prevalence of abdominal aortic aneurysms, growing preference for minimally invasive procedures, and advancements in endovascular technologies are major market growth drivers. Healthcare providers are increasingly adopting EVAR because it can offer a less invasive alternative to conventional open surgery for appropriately selected patients. Improvements in stent-graft design, delivery systems, fixation technologies, and imaging are also supporting procedural adoption.

The market is also benefiting from improved diagnostic capabilities and greater awareness of AAA screening and management. As vascular centers expand their capabilities, demand is increasing for devices capable of treating both standard and anatomically complex aneurysms. Fenestrated and branched graft technologies are creating additional opportunities by extending endovascular treatment to more challenging anatomies.

Which region leads?

North America leads the Abdominal Aortic Aneurysm (AAA) Repair Devices Market, supported by advanced healthcare infrastructure, a strong vascular surgery ecosystem, high adoption of endovascular procedures, and the presence of major medical device manufacturers. One industry analysis estimates North America accounted for approximately 42% of global market revenue in 2025.

Asia Pacific represents an attractive growth region as healthcare infrastructure, diagnostic capabilities, specialized vascular centers, and access to minimally invasive procedures continue to expand. The region is also expected to benefit from its aging population and increasing healthcare investment. Some market estimates identify Asia Pacific as the fastest-growing regional market, with growth supported by increasing adoption of advanced vascular interventions.

Which segment leads?

Endovascular Aneurysm Repair (EVAR) is the leading product or procedure segment, reflecting the increasing preference for minimally invasive treatment compared with conventional open surgical repair. EVAR uses endovascular stent-graft systems to exclude the aneurysm from blood flow and has become an important treatment option for patients with suitable anatomy.

Within the broader device landscape, stent-graft systems, delivery systems, catheters, sheaths, balloons, and guidewires are important components of AAA repair procedures. Demand is also increasing for fenestrated and branched devices designed for complex aortic anatomies. Technological developments are increasingly focused on improving deployment precision, sealing, fixation, durability, and procedural flexibility.

Which companies are prominent?

Prominent companies operating in the Artivion, Inc., Cardinal Health, Inc., Cardiatis SA, Cook Medical LLC, Endologix LLC, Getinge AB, Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, W. L. Gore & Associates, Inc.These companies compete through product innovation, expanded stent-graft portfolios, geographic expansion, strategic collaborations, and improvements in delivery and fixation technologies.

Competitive differentiation increasingly depends on the ability to address complex anatomies, improve device deployment, reduce procedural complications, and provide durable long-term performance. Manufacturers are also focusing on advanced endovascular solutions, personalized treatment approaches, and technologies that can support more efficient vascular procedures.

What is changing in 2026?

The market is shifting toward more advanced, anatomy-specific, and minimally invasive AAA repair solutions. Manufacturers are developing stent-graft systems with improved fixation, sealing, deployment control, and adaptability to challenging anatomies. Expansion into complex aortic aneurysm repair is identified as an important market trend, while advanced imaging and personalized procedural planning are also supporting treatment optimization.

Recent product developments demonstrate this direction. For example, Terumo introduced the TREO Abdominal Stent-Graft System in India in 2024, featuring a three-piece design, active fixation, in situ limb adjustability, and features intended to support proximal sealing and reduce migration risks. Such developments illustrate the industry's focus on improving procedural precision and device performance.

What are the major investment opportunities?

The strongest opportunities lie in advanced EVAR systems, complex AAA repair technologies, personalized stent-grafts, imaging-assisted procedures, and expanding vascular care infrastructure. Investment in fenestrated and branched grafts can help address patients with anatomically complex aneurysms, while improved delivery systems may enhance procedural efficiency and usability.

Emerging markets, particularly across Asia Pacific, offer additional opportunities as healthcare infrastructure and access to specialized vascular treatment improve. Companies that combine clinical performance, device durability, physician training, regulatory readiness, and cost efficiency are positioned to benefit from increasing demand for minimally invasive AAA treatment.

Related Reading / Reports

Explore additional research covering aortic disease treatment, endovascular procedures, and vascular medical devices:

• Endovascular Aneurysm Repair Market — Analysis of fenestrated, branched, and adjunctive stent-graft technologies across major regions and end users.

• Endovascular Abdominal Aortic Aneurysm Repair Devices Market — Coverage of stent-graft systems, advanced technologies, applications, and competitive developments.

• Aortic Valve Replacement Devices Market — Insights into advanced cardiovascular devices and minimally invasive treatment technologies.

• Vascular Graft Market — Analysis of vascular graft technologies, applications, end users, and regional growth opportunities.